Bacterial Infection clinical trials at UCSF
1 in progress, 0 open to new patients
Sorry, in progress, not accepting new patients
This study evaluates the safety and clinical benefit of MBN-101 administered intraoperatively to osteosynthesis or osteomyelitis sites for patients diagnosed with an orthopedic infection, with or without orthopaedic hardware. Three quarters of the patients will receive MBN-101, while the other one quarter will receive placebo.
San Francisco, California and other locations